Article Text

Download PDFPDF
Single case of lymphogranuloma venereum on the tongue
  1. Tristan Gabriel Sobral-Costas1,
  2. Sergio López-Alcázar1,
  3. Rafael Escudero-Tornero1,
  4. Guillermo Servera-Negre1,
  5. David Manuel Montenegro Pascual2,
  6. Inmaculada Quiles-Melero3,
  7. Elena Sendagorta Cudós1
  1. 1 Dermatology Department, La Paz University Hospital, Madrid, Spain
  2. 2 Internal Medicine, La Paz University Hospital, Madrid, Spain
  3. 3 La Paz University Hospital, Madrid, Spain
  1. Correspondence to Dr Tristan Gabriel Sobral-Costas, La Paz University Hospital, Madrid 28046, Spain; tristansobral{at}gmail.com

Abstract

Traditionally, lymphogranuloma venereum (LGV) has been associated with disease of the genital area. However, atypical presentations and proctitis are increasingly observed. We report a case of LGV affecting the dorsum of the tongue, which presented as a very painful ulcer. The response to doxycycline (100 mg two times per day for 21 days) was satisfactory. This case may represent a paradigm shift in the differential diagnosis of lingual ulcers.

  • Homosexuality, Male
  • LYMPHOGRANULOMA VENEREUM
  • HIV
  • Mouth

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Handling editor Anna Maria Geretti

  • Contributors SL-A, RE-T, GS-N and DMP have participated in the clinical data collection. GS-N and RE-T have also participated in the design of the article. IQ-M contributed to the microbiology data. ESC has participated in the conception of the study. TGS-C has participated in the conception, data collection, analysis of results and preparation and submission of the manuscript. All authors have read and approved the manuscript.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; internally peer reviewed.

  • Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.